Search research articles
Contact Us
Filters
Showing results (101-110 of 136) with videos related to
Page
of 14
Sort By:
Virology
|
September 19, 1998
Dominant host range selection of vaccinia recombinants by rescue of an essential gene
G W Holzer, W Gritschenberger, J A Mayrhofer, et al.
Journal of Molecular Biology
|
March 20, 2001
The energetics of the interaction of BamHI endonuclease with its recognition site GGATCC
L E Engler, P Sapienza, L F Dorner, et al.
Wiener Klinische Wochenschrift
|
May 5, 1999
Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
H P Schwarz, F Dorner, A Mitterer, et al.
Wiener Klinische Wochenschrift
|
May 5, 1999
A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production
O Kistner, P N Barrett, W Mundt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 24, 1999
Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
H P Schwarz, F Dorner, A Mitterer, et al.
Thrombosis and Haemostasis
|
August 26, 1998
Identification of mutations in the canine von Willebrand factor gene associated with type III von Willebrand disease
M Rieger, H P Schwarz, P L Turecek, et al.
AIDS Research and Human Retroviruses
|
December 31, 1998
Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization
S K Kundu, M Dupuis, A Sette, et al.
Developments in Biological Standardization
|
September 24, 1999
Development of a Vero cell-derived influenza whole virus vaccine
O Kistner, P N Barrett, W Mundt, et al.
AIDS Research and Human Retroviruses
|
April 1, 1989
Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gp160 and analysis of its immunogenicity
N Barrett, A Mitterer, W Mundt, et al.
Protein Engineering
|
October 1, 1996
Differentiation between proteolytic activation and autocatalytic conversion of human prothrombin. Activation of recombinant human prothrombin and recombinant D419N-prothrombin by snake venoms from Echis carinatus and Oxyuranus scutellatus
B E Fischer, U Schlokat, A Mitterer, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 136) with videos related to
Sort By:
Page
of 14
Virology
|
September 19, 1998
Dominant host range selection of vaccinia recombinants by rescue of an essential gene
G W Holzer, W Gritschenberger, J A Mayrhofer, et al.
Journal of Molecular Biology
|
March 20, 2001
The energetics of the interaction of BamHI endonuclease with its recognition site GGATCC
L E Engler, P Sapienza, L F Dorner, et al.
Wiener Klinische Wochenschrift
|
May 5, 1999
Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
H P Schwarz, F Dorner, A Mitterer, et al.
Wiener Klinische Wochenschrift
|
May 5, 1999
A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production
O Kistner, P N Barrett, W Mundt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 24, 1999
Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
H P Schwarz, F Dorner, A Mitterer, et al.
Thrombosis and Haemostasis
|
August 26, 1998
Identification of mutations in the canine von Willebrand factor gene associated with type III von Willebrand disease
M Rieger, H P Schwarz, P L Turecek, et al.
AIDS Research and Human Retroviruses
|
December 31, 1998
Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization
S K Kundu, M Dupuis, A Sette, et al.
Developments in Biological Standardization
|
September 24, 1999
Development of a Vero cell-derived influenza whole virus vaccine
O Kistner, P N Barrett, W Mundt, et al.
AIDS Research and Human Retroviruses
|
April 1, 1989
Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gp160 and analysis of its immunogenicity
N Barrett, A Mitterer, W Mundt, et al.
Protein Engineering
|
October 1, 1996
Differentiation between proteolytic activation and autocatalytic conversion of human prothrombin. Activation of recombinant human prothrombin and recombinant D419N-prothrombin by snake venoms from Echis carinatus and Oxyuranus scutellatus
B E Fischer, U Schlokat, A Mitterer, et al.
Page
of 14